In non-neoplastic cells, melatonin decreases GRP78 levels in stressed cells via impacts on mitochondrial function[51], with melatonin inhibiting an array of different cancer stem cells typified by high GRP78-CD44 expression[52,53]. The gene discussed is HSPA5; the disease is cancer.